Daily non-political popular news in brief.

New target for HIV/AIDS drugs and vaccine discovered

Researchers from Rome, Italy, describe a finding in the August 2007 print issue of the FASEB Journal that could lead to new drugs to fight the HIV/AIDS virus, as well as new vaccines to prevent infection. In this report, researchers demonstrate for the first time how the HIV-1 Nef viral protein delivers a one-two punch to the body's innate immune system.

Read more »

Keywords: target, hiv, aids, drugs, vaccine, discovered, aid, drug

« Previous | Next »

Similar news on "New target for HIV/AIDS drugs and vaccine discovered":

1. Nevada scientist authors influential AIDS/HIV paper
   03-08-2007 · EurekAlert!
   Due to discoveries in a key compound made by chemistry Professor Thomas Bell,a new generation of HIV/AIDS drugs is in the offing, and a new drug could be used to prevent initial infection.
   Similar news · Read more »
   
2. Bacterial walls come tumbling down
   03-09-2007 · EurekAlert!
   The first detailed images of an elusive drug target on the outer wall of bacteria may provide scientists with enough new information to aid design of novel antibiotics. The drugs are much needed to treat deadly infections initiated by Staphylococcus aureus and other bacterial pathogens.
   Similar news · Read more »
   
3. Experts urge strongest isolation for new drug-resistant tuberculosis cases appearing in South Africa
   01-22-2007 · EurekAlert!
   Medical ethics and other experts say tough isolation measures, involuntary if need be, are justified to contain a very deadly, highly-contagious and drug-resistant mutant strains of tuberculosis and to prevent "a potentially explosive international health crisis" brewing most dangerously at the epicenter of South Africa's HIV/AIDS epidemic. The new TB variations now defeat many of the world's existing drugs and pose "extreme risk."
   Similar news · Read more »
   
4. New target for anti-flu drug development
   08-15-2007 · EurekAlert!
   Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Mass., in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-flu drugs, including those that may be effective against potentially pandemic influenza strains like H5N1. The findings have been published in the Aug. 15, 2007, issue of the journal Cell Cycle. A figure from their paper was selected for the journal cover.
   Similar news · Read more »
   
5. Novel genetics research advances possibility of HIV vaccine
   07-05-2007 · EurekAlert!
   A pioneering collaborative study has discovered how the HIV virus evades the human body's immune system. The research collaborative -- involving scientists from the British Columbia Centre for Excellence in HIV/AIDS, Massachusetts General Hospital, Microsoft Research and Los Alamos National Laboratory -- used highly computer-intensive, cutting-edge statistical research methods to investigate how the HIV virus mutates to escape the body's immune system.
   Similar news · Read more »
   
6. The quest for an effective HIV vaccine presents new possibilities, challenges
   05-16-2007 · EurekAlert!
   A vaccine that prevents HIV infection remains an important goal in the fight against AIDS, but the current top HIV vaccine candidates may not work in this way, say scientists at NIAID. Rather, the first successful preventive HIV vaccines, if administered prior to HIV infection, may reduce HIV levels in the body, thereby delaying the progression to AIDS and the need to start antiretroviral drugs.
   Similar news · Read more »
   
7. Penn researchers find monkeys able to fend off AIDS-like symptoms with enhanced HIV vaccine
   11-20-2007 · EurekAlert!
   Researchers at the University of Pennsylvania School of Medicine have discovered that using an immune system gene to enhance a vaccine used to study HIV in macaque monkeys provides the animals with greater protection against simian HIV than an unmodified vaccine.
   Similar news · Read more »
   
8. Widely used hepatitis B drug spurs HIV drug resistance
   02-28-2007 · EurekAlert!
   A Johns Hopkins study has proven false established medical practice that an antiretroviral drug widely used to treat hepatitis B liver infections was safe to use on its own in patients co-infected with HIV. Their findings demonstrate that treatment with entecavir leads to cross-resistance to other antiviral drugs used to treat the AIDS virus.
   Similar news · Read more »
   
9. Discovery of an HIV inhibitor in human blood points to new drug class
   04-19-2007 · EurekAlert!
   A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying. The virus blocker might play a role in the progression of HIV to full-blown AIDS and -- because it works in a different way than existing antiretroviral inhibitors -- could lead to the development of another class of drugs in the fight against the pandemic disease.
   Similar news · Read more »
   
10. HIV isolate from Kenya provides clues for vaccine design
    01-02-2008 · EurekAlert!
    Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine.
    Similar news · Read more »